GENEVA, Feb. 15 -- DUALITY BIOLOGICS (SUZHOU) CO., LTD. (Unit 301, Building 3, Zone B, Biomedical Industrial Park Phase 3, No. 99, Jingu Road, Suzhou Industrial ParkSuzhou, Jiangsu 215000), 映恩生物制药(苏州)有限公司 (中国江苏省苏州市苏州工业园区金谷路99号生物医药产业园三期B区项目3号楼301单元) filed a patent application (PCT/CN2024/109485) for "ANTIBODY RECOGNIZING ANTIBODY-DRUG CONJUGATE AND USE THEREOF" on Aug 02, 2024. With publication no. WO/2025/03128...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.